208 related articles for article (PubMed ID: 23872551)
1. Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus.
Morgan ND; Patel SV; Dvorkina O
J Clin Rheumatol; 2013 Aug; 19(5):286-8. PubMed ID: 23872551
[No Abstract] [Full Text] [Related]
2. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia.
Chen CY; Wang FL; Lin CC
Clin Toxicol (Phila); 2006; 44(2):173-5. PubMed ID: 16615675
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine-induced ototoxicity in a child with systemic lupus erythematosus.
Lim SC; Tang SP
Int J Rheum Dis; 2011 Feb; 14(1):e1-2. PubMed ID: 21303469
[No Abstract] [Full Text] [Related]
4. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
Reynaert S; Setterfield J; Black MM
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
[No Abstract] [Full Text] [Related]
5. QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine.
Nishiyama T; Kondo Y; Tsuboi H; Noma H; Tabuchi D; Sugita T; Okamoto S; Terasaki T; Shimizu M; Honda F; Ohyama A; Kurata I; Yagishita M; Abe S; Takahashi H; Osada A; Hagiwara S; Matsumoto I; Sumida T
Mod Rheumatol; 2021 Nov; 31(6):1107-1112. PubMed ID: 33496215
[TBL] [Abstract][Full Text] [Related]
6. [Acute generalized exanthematous pustulosis included by hydroxychloroquine during lupus].
Fain O; Stirnemann J; Kettaneh A
Rev Prat; 2010 Jan; 60(1):20. PubMed ID: 20222305
[No Abstract] [Full Text] [Related]
7. Hydroxychloroquine-induced hyperpigmentation.
Tracy CL; Blakey B; Parker G; Roebuck J
J Clin Rheumatol; 2013 Aug; 19(5):292. PubMed ID: 23884186
[No Abstract] [Full Text] [Related]
8. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
[TBL] [Abstract][Full Text] [Related]
9. Ototoxicity due to hydroxychloroquine: report of two cases.
Johansen PB; Gran JT
Clin Exp Rheumatol; 1998; 16(4):472-4. PubMed ID: 9706431
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine myopathy.
Richards AJ
J Rheumatol; 1998 Aug; 25(8):1642-3. PubMed ID: 9712114
[TBL] [Abstract][Full Text] [Related]
11. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
Chiang E; Jampol LM; Fawzi AA
Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
[No Abstract] [Full Text] [Related]
12. Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report.
Abdel Galil SM
Lupus; 2015 May; 24(6):638-40. PubMed ID: 25424894
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus.
Wang WM; Wang KY; Wang T; Jin HZ; Fang K
Chin Med J (Engl); 2018 Aug; 131(15):1887-1888. PubMed ID: 30058593
[No Abstract] [Full Text] [Related]
14. Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing.
Khubchandani SR; Bichle LS
Ultrastruct Pathol; 2013 Apr; 37(2):146-50. PubMed ID: 23573895
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the risk of QTc prolongation associated with hydroxychloroquine use with antidepressants in lupus patients with fibromyalgia.
Renaldi J; Koumpouras F; Dong X
Lupus; 2021 Oct; 30(11):1844-1848. PubMed ID: 34353174
[TBL] [Abstract][Full Text] [Related]
16. Hydroxycholoroquine-induced hyperpigmentation.
Mir A; Boyd KP; Meehan SA; McLellan B
Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
[TBL] [Abstract][Full Text] [Related]
17. [The therapy of systemic lupus erythematosus].
Ochsendorf FR; Runne U
Dtsch Med Wochenschr; 1997 Jul; 122(27):877. PubMed ID: 9280702
[No Abstract] [Full Text] [Related]
18. Evidence for risk of cardiomyopathy with hydroxychloroquine.
Sumpter MD; Tatro LS; Stoecker WV; Rader RK
Lupus; 2012 Dec; 21(14):1594-6. PubMed ID: 23036986
[No Abstract] [Full Text] [Related]
19. Central variant of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: new associations?
Bag AK; Curé JK; Sullivan JC; Roberson GH
Lupus; 2010 Feb; 19(2):225-6. PubMed ID: 19880556
[No Abstract] [Full Text] [Related]
20. Successful desensitization for hydroxychloroquine anaphylaxis.
Donado CD; Díez EM
J Rheumatol; 2010 Sep; 37(9):1975-6. PubMed ID: 20810530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
